Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Heron Therapeutics Retained Earnings (Accumulated Deficit) 2010-2024 | HRTX

Heron Therapeutics retained earnings (accumulated deficit) from 2010 to 2024. Retained earnings (accumulated deficit) can be defined as profits reinvested in the corporation after dividends have been paid out.
  
Heron Therapeutics Annual Retained Earnings (Accumulated Deficit)
(Millions of US $)
2023 $-1,906
2022 $-1,795
2021 $-1,613
2020 $-1,393
2019 $-1,165
2018 $-961
2017 $-783
2016 $-586
2015 $-413
2014 $-315
2013 $-239
2012 $-184
2011 $-160
2010 $-148
2009 $-141
Heron Therapeutics Quarterly Retained Earnings (Accumulated Deficit)
(Millions of US $)
2024-09-30 $-1,923
2024-06-30 $-1,918
2024-03-31 $-1,909
2023-12-31 $-1,906
2023-09-30 $-1,895
2023-06-30 $-1,870
2023-03-31 $-1,828
2022-12-31 $-1,795
2022-09-30 $-1,776
2022-06-30 $-1,734
2022-03-31 $-1,677
2021-12-31 $-1,613
2021-09-30 $-1,559
2021-06-30 $-1,506
2021-03-31 $-1,445
2020-12-31 $-1,393
2020-09-30 $-1,330
2020-06-30 $-1,272
2020-03-31 $-1,217
2019-12-31 $-1,165
2019-09-30 $-1,108
2019-06-30 $-1,074
2019-03-31 $-1,024
2018-12-31 $-961
2018-09-30 $-911
2018-06-30 $-873
2018-03-31 $-834
2017-12-31 $-783
2017-09-30 $-721
2017-06-30 $-679
2017-03-31 $-636
2016-12-31 $-586
2016-09-30 $-538
2016-06-30 $-489
2016-03-31 $-446
2015-12-31 $-413
2015-09-30 $-382
2015-06-30 $-359
2015-03-31 $-336
2014-12-31 $-315
2014-09-30 $-295
2014-06-30 $-275
2014-03-31 $-256
2013-12-31 $-239
2013-09-30 $-225
2013-06-30 $-212
2013-03-31 $-197
2012-12-31 $-184
2012-09-30 $-176
2012-06-30 $-170
2012-03-31 $-165
2011-12-31 $-160
2011-09-30 $-156
2011-06-30 $-152
2011-03-31 $-150
2010-12-31 $-148
2010-09-30 $-147
2010-06-30 $-145
2010-03-31 $-142
2009-12-31 $-141
2009-09-30 $-139
2009-06-30 $-138
2009-03-31 $-134
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.257B $0.127B
Heron Therapeutics Inc. is a specialty pharmaceutical company. The company is developing products using its proprietary Biochronomer (TM) polymer-based drug delivery platform. Its product portfolio includes APF530, is being developed for the prevention of acute chemotherapy-induced nausea and vomiting. Heron Therapeutics Inc., formerly known as A.P. Pharma, Inc., is based in REDWOOD CITY CA.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $79.873B 31.52
Zoetis (ZTS) United States $70.142B 26.46
Daiichi Sankyo, - (DSNKY) $43.872B 26.73
Takeda Pharmaceutical (TAK) Japan $43.719B 9.68
Sandoz Group AG (SDZNY) Switzerland $20.592B 0.00
Merck (MKKGY) Germany $18.255B 16.35
Astellas Pharma (ALPMY) Japan $17.355B 12.30
United Therapeutics (UTHR) United States $17.000B 16.72
Summit Therapeutics (SMMT) United States $15.929B 0.00
Shionogi (SGIOY) Japan $12.267B 12.29
Neurocrine Biosciences (NBIX) United States $11.392B 34.73
Corcept Therapeutics (CORT) United States $7.704B 58.36
Madrigal Pharmaceuticals (MDGL) United States $7.495B 0.00
Orion OYJ (ORINY) Finland $7.424B 20.87
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.245B 0.00
Stevanato Group S.p.A (STVN) Italy $6.166B 39.92
Grifols, S.A (GRFS) Spain $5.074B 0.00
Ionis Pharmaceuticals (IONS) United States $5.023B 0.00
Ono Pharmaceutical (OPHLF) Japan $4.650B 9.52
Recursion Pharmaceuticals (RXRX) United States $4.247B 0.00
Crinetics Pharmaceuticals (CRNX) United States $3.394B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.687B 12.18
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.432B 14.54
Hypermarcas (HYPMY) Brazil $2.185B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $2.098B 0.00
Soleno Therapeutics (SLNO) United States $2.047B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.945B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $1.766B 0.00
Evotec AG (EVO) Germany $1.566B 0.00
Ardelyx (ARDX) United States $1.506B 0.00
Indivior (INDV) United States $1.504B 6.13
Dyne Therapeutics (DYN) United States $1.406B 0.00
Guardian Pharmacy Services (GRDN) United States $1.323B 0.00
ARS Pharmaceuticals (SPRY) United States $1.166B 0.00
Ocular Therapeutix (OCUL) United States $1.160B 0.00
Xencor (XNCR) United States $1.134B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.127B 0.00
Harrow (HROW) United States $1.078B 0.00
Enliven Therapeutics (ELVN) United States $1.070B 0.00
Collegium Pharmaceutical (COLL) United States $0.965B 5.27
Bioventus (BVS) United States $0.838B 26.46
Avadel Pharmaceuticals (AVDL) Ireland $0.810B 0.00
Cronos Group (CRON) Canada $0.750B 0.00
Relay Therapeutics (RLAY) United States $0.696B 0.00
Verve Therapeutics (VERV) United States $0.683B 0.00
USANA Health Sciences (USNA) United States $0.595B 11.02
Xeris Biopharma Holdings (XERS) United States $0.592B 0.00
KalVista Pharmaceuticals (KALV) United States $0.529B 0.00
OmniAb (OABI) United States $0.518B 0.00
Elite Pharmaceuticals (ELTP) United States $0.509B 0.00
Altimmune (ALT) United States $0.482B 0.00
Savara (SVRA) United States $0.481B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.479B 0.00
ProKidney (PROK) United States $0.458B 0.00
Organogenesis (ORGO) United States $0.444B 0.00
Akebia Therapeutics (AKBA) United States $0.432B 0.00
Siga Technologies (SIGA) United States $0.431B 5.03
Zevra Therapeutics (ZVRA) United States $0.413B 0.00
Aldeyra Therapeutics (ALDX) United States $0.404B 0.00
Oruka Therapeutics (ORKA) United States $0.377B 0.00
Esperion Therapeutics (ESPR) United States $0.374B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.363B 147.29
Tourmaline Bio (TRML) United States $0.323B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.310B 0.00
CytoDyn (CYDY) United States $0.292B 0.00
Korro Bio (KRRO) United States $0.276B 0.00
Aquestive Therapeutics (AQST) United States $0.276B 0.00
Avita Medical (RCEL) United States $0.268B 0.00
Nature's Sunshine Products (NATR) United States $0.264B 15.71
Innate Pharma SA (IPHYF) France $0.243B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.241B 0.00
4D Molecular Therapeutics (FDMT) United States $0.219B 0.00
Inhibikase Therapeutics (IKT) United States $0.214B 0.00
Profound Medical (PROF) Canada $0.213B 0.00
Larimar Therapeutics (LRMR) United States $0.211B 0.00
MediWound (MDWD) Israel $0.199B 0.00
Nektar Therapeutics (NKTR) United States $0.184B 0.00
Lyell Immunopharma (LYEL) United States $0.181B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.177B 0.00
Nanobiotix S.A (NBTX) France $0.170B 0.00
Acrivon Therapeutics (ACRV) United States $0.165B 0.00
Aclaris Therapeutics (ACRS) United States $0.165B 0.00
VAXART, INC (VXRT) United States $0.165B 0.00
Procaps Group, S.A (PROCF) Luxembourg $0.150B 0.00
Silence Therapeutics (SLN) United Kingdom $0.150B 0.00
Champions Oncology (CSBR) United States $0.149B 0.00
Lexeo Therapeutics (LXEO) United States $0.147B 0.00
Cassava Sciences (SAVA) United States $0.134B 0.00
Inotiv (NOTV) United States $0.132B 0.00
ElectroCore (ECOR) United States $0.129B 0.00
Telomir Pharmaceuticals (TELO) United States $0.125B 0.00
Achieve Life Sciences (ACHV) Canada $0.110B 0.00
Journey Medical (DERM) United States $0.104B 0.00
Cardiol Therapeutics (CRDL) Canada $0.101B 0.00
Metagenomi (MGX) United States $0.096B 0.00
Galectin Therapeutics (GALT) United States $0.095B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.095B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.087B 0.00
Arch Biopartners (ACHFF) Canada $0.086B 0.00
Regulus Therapeutics (RGLS) United States $0.085B 0.00
Protara Therapeutics (TARA) United States $0.082B 0.00
Pyxis Oncology (PYXS) United States $0.080B 0.00
Nutriband (NTRB) United States $0.080B 0.00
ESSA Pharma (EPIX) Canada $0.077B 0.00
Assertio Holdings (ASRT) United States $0.077B 20.08
Karyopharm Therapeutics (KPTI) United States $0.076B 0.00
PMV Pharmaceuticals (PMVP) United States $0.075B 0.00
Dominari Holdings (DOMH) United States $0.074B 0.00
Mural Oncology (MURA) Ireland $0.073B 0.00
Avalo Therapeutics (AVTX) United States $0.073B 0.00
Vivani Medical (VANI) United States $0.070B 0.00
Fractyl Health (GUTS) United States $0.070B 0.00
Century Therapeutics (IPSC) United States $0.064B 0.00
Gain Therapeutics (GANX) United States $0.064B 0.00
Context Therapeutics (CNTX) United States $0.063B 0.00
Unicycive Therapeutics (UNCY) United States $0.062B 0.00
AleAnna (ANNA) United States $0.062B 0.00
OptiNose (OPTN) United States $0.060B 0.00
FibroGen (FGEN) United States $0.057B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.056B 0.00
AlloVir (ALVR) United States $0.052B 0.00
Iterum Therapeutics (ITRM) Ireland $0.051B 0.00
Rafael Holdings (RFL) United States $0.051B 0.00
Prelude Therapeutics (PRLD) United States $0.050B 0.00
SCYNEXIS (SCYX) United States $0.042B 0.00
Tempest Therapeutics (TPST) United States $0.040B 0.00
NRx Pharmaceuticals (NRXP) United States $0.040B 0.00
Surrozen (SRZN) United States $0.039B 0.00
CASI Pharmaceuticals (CASI) China $0.038B 0.00
VYNE Therapeutics (VYNE) United States $0.037B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.034B 0.00
BioVie (BIVI) United States $0.032B 0.00
PolyPid (PYPD) Israel $0.030B 0.00
Incannex Healthcare (IXHL) Australia $0.029B 0.00
Jupiter Neurosciences (JUNS) United States $0.028B 0.00
Natural Alternatives (NAII) United States $0.026B 0.00
DURECT (DRRX) United States $0.025B 0.00
Scienture Holdings (SCNX) United States $0.025B 0.00
Enlivex Therapeutics (ENLV) Israel $0.022B 0.00
Mannatech (MTEX) United States $0.021B 0.00
GlycoMimetics (GLYC) United States $0.020B 0.00
Carisma Therapeutics (CARM) United States $0.020B 0.00
Vivos Therapeutics (VVOS) United States $0.019B 0.00
Lipocine (LPCN) United States $0.019B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.019B 0.00
Citius Pharmaceuticals (CTXR) United States $0.018B 0.00
MEI Pharma (MEIP) United States $0.018B 0.00
Traws Pharma (TRAW) United States $0.017B 0.00
Biomerica (BMRA) United States $0.017B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.017B 0.00
Cosmos Health (COSM) United States $0.015B 0.00
Mangoceuticals (MGRX) United States $0.014B 0.00
ProPhase Labs (PRPH) United States $0.014B 0.00
Minerva Neurosciences (NERV) United States $0.013B 0.00
Lyra Therapeutics (LYRA) United States $0.013B 0.00
BioLineRx (BLRX) Israel $0.013B 0.00
Jaguar Animal Health (JAGX) United States $0.012B 0.00
Phio Pharmaceuticals (PHIO) United States $0.012B 0.00
TherapeuticsMD (TXMD) United States $0.012B 0.00
Nuvilex (PMCB) United States $0.011B 0.00
Talphera (TLPH) United States $0.011B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.011B 0.00
Indaptus Therapeutics (INDP) United States $0.010B 0.00
Klotho Neurosciences (KLTO) United States $0.010B 0.00
Relmada Therapeutics (RLMD) United States $0.010B 0.00
Ainos (AIMD) United States $0.009B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.008B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.008B 0.00
Addex Therapeutics (ADXN) Switzerland $0.008B 0.00
Plus Therapeutics (PSTV) United States $0.007B 0.00
TransCode Therapeutics (RNAZ) United States $0.007B 0.00
Redhill Biopharma (RDHL) Israel $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Aptorum Group (APM) United Kingdom $0.006B 0.00
Clearmind Medicine (CMND) Canada $0.006B 0.00
CERo Therapeutics Holdings (CERO) United States $0.005B 0.00
SciSparc (SPRC) Israel $0.005B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.004B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.003B 0.00
Avenue Therapeutics (ATXI) United States $0.003B 0.08
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.003B 0.00
Alaunos Therapeutics (TCRT) United States $0.002B 0.00
InMed Pharmaceuticals (INM) Canada $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
SHINECO (SISI) China $0.002B 0.00
Heatwurx (PCSA) United States $0.002B 0.00
Aditxt (ADTX) United States $0.002B 0.00
Petros Pharmaceuticals (PTPI) United States $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.002B 0.00
China SXT Pharmaceuticals (SXTC) China $0.002B 0.00
TNF Pharmaceuticals (TNFA) United States $0.001B 0.00
Conduit Pharmaceuticals (CDT) United States $0.001B 0.00
PainReform (PRFX) Israel $0.001B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00